Literature DB >> 2537763

Immunoquantitation of 80 kDa diacylglycerol kinase in pig and human lymphocytes and several other cells.

K Yamada1, F Sakane, H Kanoh.   

Abstract

80 kDa diacylglycerol kinase (DGK) was immunoquantitated in cell homogenates and subcellular fractions. It was extremely abundant in the cytosol of various lymphocytes and comprised, in the highest case, more than 0.2% of the total soluble protein in T cell-enriched pig splenocytes. The lymphocyte membrane contained less than 10% of the total cellular DGK protein. The content of 80 kDa DGK in the human T cell leukemic cell line, Jurkat (360 ng/mg homogenate protein), was similar to those in pig and human peripheral blood lymphocytes. In contrast, the enzyme level was very low in the human promyeloblastic cell line, HL-60 (less than 10 ng/mg homogenate protein), and was undetectable in human polymorphonuclear leukocytes. These findings indicate that the content of 80 kDa DGK is markedly variable depending on the type of cells, even though all these cells are known to accumulate phosphatidate rapidly upon cell stimulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537763     DOI: 10.1016/0014-5793(89)80572-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

Review 1.  Phosphatidyl inositol metabolism and its role in signal transduction in growing plants.

Authors:  L Lehle
Journal:  Plant Mol Biol       Date:  1990-10       Impact factor: 4.076

2.  Effect of R59022, an inhibitor of diacylglycerol kinase, on IgE-mediated histamine release from human lung mast cells and basophils.

Authors:  K L O'Keefe; J A Warner
Journal:  Agents Actions       Date:  1994-11

3.  Diacylglycerol kinase is phosphorylated in vivo upon stimulation of the epidermal growth factor receptor and serine/threonine kinases, including protein kinase C-epsilon.

Authors:  D Schaap; J van der Wal; W J van Blitterswijk; R L van der Bend; H L Ploegh
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

4.  FoxO-dependent regulation of diacylglycerol kinase α gene expression.

Authors:  Mónica Martínez-Moreno; Job García-Liévana; Denise Soutar; Pedro Torres-Ayuso; Elena Andrada; Xiao-Ping Zhong; Gary A Koretzky; Isabel Mérida; Antonia Ávila-Flores
Journal:  Mol Cell Biol       Date:  2012-08-13       Impact factor: 4.272

5.  Distribution of distinct arachidonoyl-specific and non-specific isoenzymes of diacylglycerol kinase in baboon (Papio cynocephalus) tissues.

Authors:  R N Lemaitre; W C King; M L MacDonald; J A Glomset
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

6.  EF-hand motifs of alpha, beta and gamma isoforms of diacylglycerol kinase bind calcium with different affinities and conformational changes.

Authors:  K Yamada; F Sakane; N Matsushima; H Kanoh
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

7.  The C-terminal part of diacylglycerol kinase alpha lacking zinc fingers serves as a catalytic domain.

Authors:  F Sakane; M Kai; I Wada; S Imai; H Kanoh
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

8.  Isolation and characterization of the human diacylglycerol kinase gene.

Authors:  K Fujikawa; S Imai; F Sakane; H Kanoh
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

9.  A novel diacylglycerol kinase α-selective inhibitor, CU-3, induces cancer cell apoptosis and enhances immune response.

Authors:  Ke Liu; Naoko Kunii; Megumi Sakuma; Atsumi Yamaki; Satoru Mizuno; Mayu Sato; Hiromichi Sakai; Sayaka Kado; Kazuo Kumagai; Hirotatsu Kojima; Takayoshi Okabe; Tetsuo Nagano; Yasuhito Shirai; Fumio Sakane
Journal:  J Lipid Res       Date:  2016-01-14       Impact factor: 5.922

10.  Diacylglycerol kinase-dependent formation of phosphatidic acid molecular species during interleukin-2 activation in CTLL-2 T-lymphocytes.

Authors:  Satoru Mizuno; Hiromichi Sakai; Masafumi Saito; Sayaka Kado; Fumio Sakane
Journal:  FEBS Open Bio       Date:  2012-09-04       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.